influenza, pneumonia, COVID-19, diagnosis


Influenza viruses, in particular A ‒ A(H3N2) and A(H1N1)pdm09, as well as influenza B virus, mainly (98%) of the B/Victoria line, continue to circulate during the current epidemic season. The level of influenza vaccination remains low, about 0.6% of the population of Ukraine, and among occupational and epidemiological risk groups ‒ 22.8%, according to the Public Health Centre of the Ministry of Health of Ukraine. In the COVID-19 pandemic, simultaneous circulation of influenza viruses and SARS-CoV-2 can lead to difficulties in differential diagnosis and treatment. Comparison of clinical and laboratory features of severe influenza complicated by pneumonia caused by pandemic influenza virus A(H1N1)pdm09 in the epidemic season of 2015/2016 Kharkiv RCIDH with COVID-19 on clinical and laboratory data was the aim of the work. Patients and research methods. The analysis of clinical symptoms and laboratory examination data of 19 patients with influenza complicated by community-acquired pneumonia of clinical group IV who were treated at the Kharkiv Regional Hospital and their comparison with those of patients with COVID-19 according to the literature. Results and discussion. Among the studied patients, men predominated ‒ 12 persons (63.2%) aged 50.68±11.95 years. The predominant number had concomitant diseases. At the beginning of the disease, moderate weakness, headache, fever, minor catarrhal phenomena and, as a result, delayed hospitalization prevailed. From 3‒4 days of the disease the condition significantly worsened, shortness of breath and cyanosis joined. Typical initial symptoms of COVID-19 are fever of varying degrees (73%), unproductive cough (59%) and shortness of breath or shortness of breath. Conclusions. In patients with COVID-19 and severe influenza, a more acute onset of the disease was reported, with moderate weakness, headache and fever up to 38°C and symptoms of pharyngitis. Influenza patients often show a delay in seeking medical attention and hospitalization for 6.21±1.46 days of illness. The severity of the disease in influenza is due to the accession of community-acquired pneumonia, in contrast to COVID-19, where the typical features are diffuse, mostly subpleural lung affection. Vaccination of people at risk before the start of the epidemic season is necessary to prevent severe complications of influenza caused by the pandemic virus A(H1N1)pdm09 in the context of the COVID-19 pandemic.

Keywords: influenza, pneumonia, COVID-19, diagnosis


Season overview (n.d.). Retrieved December 24, 2021, from

European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Flu News Europe, Joint ECDC–WHO weekly influenza up date, week 49/2021. [Online]. Retrieved from

European Centre for Disease Prevention and Control. Seasonal influenza. [Online]. Retrieved from

Zakhvoryvanist na grip ta GRVI v Ukraini [incidence of Influenza and AVRD in Ukraine]. Center hromadskogo zdorovya [Public Health Center]. (2020). Retrieved October 11, 2020, from inshi-infekciyni-zakhvoryuvannya/monitoring-i-ocinka/zakhvoryuvanist-na-grip-ta-grvi-v-ukraini.

Short, K. R., Kasper, J., van der Aa, S., Andeweg, A. C., Zaaraoui-Boutahar, F., Goeijenbier, M., … & Kui-ken, T. (2016). Influenza virus damages the alveolar barrier by disrupting epithelial cell tight junctions. European Res-piratory Journal, 47(3), 954–966.

Pérez-Carrasco, M., Lagunes, L., Antón, A., Gattarello, S., Laborda, C., Pumarola, T., … & CRIPS investiga-tors (2016). Influenza infection in the intensive care unit: Four years after the 2009 pandemic. Enfermedades infecciosas y microbiologia clinica, 34(3), 177–183.

Perez-Padilla, R., de la Rosa-Zamboni, D., Ponce de Leon, S., Hernandez, M., Quiñones-Falconi, F., Bautista, E., … & INER Working Group on Influenza (2009). Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. The New England journal of medicine, 361(7), 680–689.

Katsapv, D., Kozko, V., Bondarenko, A., et al. (2015). Analiz kliniko-laboratornych aspectiv pandemichnogo gryppu A (H1N1) ta yogo uskladnen v Kharkivskiy oblasty [Title of article]. In Epidemiologia, ekologiya I gi-giena: Proceedings of the Conference, Kharkiv, 2011. (Pp. 108–112). Kharkiv: KNMU. [In Ukrainian].

Sanyaolu, A., Okorie, C., Marinkovic, A., Haider, N., Abbasi, A. F., Jaferi, U., … & Balendra, V. (2021). The emerging SARS-CoV-2 variants of concern. Therapeutic advances in infectious disease, 8, 20499361211024372.

Shi, H., Han, X., Jiang, N., Cao, Y., Alwalid, O., Gu, J., … & Zheng, C. (2020). Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet. Infectious diseases, 20(4), 425–434.

Yurko, K. V., Katsapov, D. V., Bondarenko, А. V., Nartov, P. V., Maksul, Т. Y., & Harchenko, О. M. (2021). Kliniko-laboratorna haracteristica letalnich vipadciv vid pandemichnogo gripu А/H1N1 porivnjano z tyagkimi formami COVID-19 [Clinical and laboratory characteristics of lethal cases of pandemic influenza А/H1N1 in compari-son with severe forms of COVID-19]. Infekciini hvorobi [Infectious diseases], (3), 21‒26.

Marlene, M. S., Singer-Cornelius, Th., Obere, M., Gengler, I., Brockmeier, S. J., & Sedaghat, A. R. (2020). Olfactory dysfunction and sinonasal symptomatology in COVID-19: 3 prevalence, severity, timing and associated char-acteristics. [Online]. Retrieved from sedaghat_2_olfactory_dysfunction_ and_sinonasal_symptomatology_in_covid-19.pdf [unpublished].

Qureshi, N. R., Hien, T. T., Farrar, J., & Gleeson, F. V. (2006). The radiologic manifestations of H5N1 avian influenza. Journal of thoracic imaging, 21(4), 259–264.

Zhang, S., Liu, Y., Wang, X., Yang, L., Li, H., Wang, Y., … & Hu, L. (2020). SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19. Journal of hematology & oncology, 13(1), 120.

Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., … & Rodriguez-Morales, A. J. (2020). Coronavirus Disease 2019-COVID-19. Clinical microbiology reviews, 33(4), e00028-20.

Copyright for articles published in the journal is regulated by the License Agreement for the use of a scientific article in the journal, which is concluded between the author of the article (Licensor) and Kharkov National Medical University (Licensee, publisher of the journal "Inter Collegas"). The licensor grants to the Licensee a non-exclusive non-exclusive license for the use of the article (a license that does not exclude the use of the article by the Licensor and the issuance of licenses to others for use of this article) on the terms and for the period specified in the contract. The licensor (the author of the article) grants the Licensee the right to reproduce the article (publication in the journal "Inter Collegas", publication, duplication, duplication or other reproduction of the article without limiting the circulation of copies, each copy of the article must contain the name of the Licensor; Of general information, including the publication of the article in full or in part on the Internet on the journal page, the right to use the metadata of the article (titles, full names of authors, annotations, bibliography eskih materials) through the dissemination and communication to the public, processing and systematization, as well as inclusion in various databases and in-formational system).

The licensor grants the licensee the right to transfer, store and process his personal data (full name, scientific degree, academic title, place of work and position, contact information of the authors) with the purpose of including them in the database in accordance with the Law of Ukraine No. 2297 - VI "on protection of personal data" from 01.06.2010.

Personal data and metadata of the article are provided for their storage and processing in various databases and information systems, including them in analytical and statistical reporting, creating sound relationships between the objects of works of science, literature and art with personal data, etc. on unlimited territory. The licensee has the right to transfer the specified data for processing and storage to third parties provided that such a fact is notified with the provision of information about the third party (name and address) to the Licensor.